(Q73904661)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957275%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

How low is the alpha/beta ratio for prostate cancer? In regard to Wang et al., IJROBP 2003;55:194-203 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957275%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

Jack F Fowler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957275%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Mark A Ritter

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957275%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

John D Fenwick

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957275%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Rick J Chappell

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957275%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 October 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957275%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Radiation Oncology Biology Physics

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957275%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957275%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957275%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

593-5; author reply 595-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957275%20AND%20SRC:MED&resulttype=core&format=json

How low is the alpha/beta ratio for prostate cancer?

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900364-X

7 January 2021

Is alpha/beta for prostate tumors really low?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900364-X

7 January 2021

Fractionation and protraction for radiotherapy of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900364-X

7 January 2021

Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900364-X

7 January 2021

What hypofractionated protocols should be tested for prostate cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900364-X

7 January 2021

The delay before onset of accelerated tumour cell repopulation during radiotherapy: a direct maximum-likelihood analysis of a collection of worldwide tumour-control data

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900364-X

7 January 2021

Predictive value of potential doubling time in head and neck cancer patients treated by conventional radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900364-X

7 January 2021

Rapid repopulation in radiotherapy: a debate on mechanism. The phantom of tumor treatment--continually rapid proliferation unmasked

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900364-X

7 January 2021

A comment on proliferation rates in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900364-X

7 January 2021

Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900364-X

7 January 2021

Fractionation parameters for human tissues and tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900364-X

7 January 2021

Repair capacity and kinetics for human mucosa and epithelial tumors in the head and neck: clinical data on the effect of changing the time interval between multiple fractions per day in radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900364-X

7 January 2021

Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900364-X

7 January 2021

Is the alpha/beta for prostate tumors really low? In regard to Fowler et al., IJROBP 2001;50:1021-1031.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900364-X

7 January 2021

Tumour control probability: a formulation applicable to any temporal protocol of dose delivery.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900364-X

7 January 2021

Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: pitfalls in deducing radiobiologic parameters for tumors from clinical data

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900364-X

7 January 2021

10.1016/S0360-3016(03)00364-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12957275%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference